In 2022, the global HIV AIDS Immunoassay Diagnostic Market reached a size of USD 2.5 billion, and according to the latest report from Reports and Data, it is anticipated to exhibit a revenue compound annual growth rate (CAGR) of 5.5% throughout the forecast period.
The HIV/AIDS pandemic on a global scale primarily impacts countries with lower and middle income levels, with Sub-Saharan Africa experiencing the highest number of new infections. The surge in demand for HIV/AIDS immunoassay diagnostic tests can be attributed to the increased efforts of international entities like UNAIDS and governments in addressing the epidemic. Initiatives such as broadening access to antiretroviral medication (ART) and prevention campaigns have contributed to this demand. For instance, in 2019, the World Health Organization (WHO) launched the “Test and Treat” campaign aimed at raising awareness about the HIV status of individuals and providing them with ART.
Access Free sample PDF Copy of the Report @
https://www.reportsanddata.com/download-free-sample/6844
Furthermore, advancements in technology have led to the creation of highly sensitive and specific immunoassay diagnostic tests for HIV/AIDS, which are expected to drive the growth in market revenue. The adoption of HIV/AIDS immunoassay diagnostic tests has also risen due to the emergence of point-of-care (POC) immunoassay diagnostic assays that can deliver results within minutes. A significant development in this regard occurred in 2020 when the FDA approved the first rapid POC immunoassay diagnostic test for HIV-1 and HIV-2.
Key players in the HIV AIDS Immunoassay Diagnostic Market:
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Chembio Diagnostics, Inc.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Merck KGaA
- Ortho Clinical Diagnostics
- Qiagen N.V.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Some Key Highlights in the Report:
- In 2021, the ELISA segment dominated the market in terms of revenue share. Factors propelling the growth of this segment include the increasing prevalence of HIV/AIDS, the demand for precise and dependable diagnostic tests, and the growing awareness of illnesses.
- Hospitals held the highest revenue share in the global HIV/AIDS immunoassay diagnostic market in 2021. This can be attributed to the significant patient flow in hospitals, their access to advanced infrastructure and diagnostic equipment, as well as their specialized medical teams experienced in managing infectious diseases like HIV/AIDS. Additionally, government funding and initiatives aimed at curtailing the spread of HIV/AIDS are expected to bolster the growth of the hospital sector throughout the projected period.
- The Asia Pacific region is anticipated to witness an upsurge in demand for HIV/AIDS immunoassay diagnostics due to increased disease awareness and government efforts to curb the spread of HIV/AIDS. Moreover, the rising prevalence of HIV/AIDS in emerging markets such as India and China is expected to drive demand for HIV/AIDS immunoassay diagnostics in the region.
- In October 2021, Abbott Laboratories obtained CE Mark clearance for their advanced HIV-1 and HIV-2 Blood Screening assay. This assay is designed to detect HIV infections with greater accuracy and at an earlier stage, ultimately leading to improved patient outcomes and reduced transmission rates.
- In September 2021, Becton, Dickinson and Company introduced a rapid diagnostic test for HIV, hepatitis B and C, as well as syphilis. This test can provide results in as little as 15 minutes, enabling healthcare practitioners to diagnose and treat patients more expeditiously.
Get in detailed Research Study @
https://www.reportsanddata.com/report-detail/hiv-aids-immunoassay-diagnostic-market
For the purpose of this report, Reports and Data has segmented the global HIV/AIDS immunoassay diagnostic market on the basis of Product Type Outlook, End-use Outlook, and Regional Outlook:
Product Type Outlook (Revenue, USD Billion; 2022 – 2032)
- ELISA
- Rapid Tests
- Western Blot
- Home Test Kits
- Others
End-use Outlook (Revenue, USD Billion; 2022 – 2032)
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/6844
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @
https://www.reportsanddata.com/request-customization-form/6844
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Cancer Stem Cell (CSC) Therapeutics Market, By Type, By Cancer Type (Breast Cancer, Blood Cancer, Lung Cancer, Brain Cancer, Colorectal Cancer, Liver Cancer, Others Cancer), By Application, By Region Forecast to 2030
Cancer Biomarkers Market by Type (Protein Biomarkers, Genetic Biomarkers, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By Application (Diagnosis, Prognosis, Treatment), By Region Forecast to 2032
Cardiovascular Devices Market By Product Type (Diagnostic and Monitoring Devices, Surgical Devices, and Therapeutic Devices), By Application (Coronary Artery Disease, Heart Failure, Cardiac Arrhythmia, Others), By Region Forecast to 2032
Cardiac Arrhythmias Monitoring Devices Market By Type (Implantable, Wearable, External), By Application (Hospitals, Clinics, Home Care Settings, Others), By Region Forecast to 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/hiv-aids-immunoassay-diagnostic-market